Our Business
Promote businesses’ systematic development and consolidate the incubation capacity to accelerate the industry chain of both bio-pharmaceutical and health resource
Tasly Pharma. Group Co.,Ltd
As an international modern Chinese medicine enterprise, Tasly Pharma.(Stock code: 600535) is committed to developing into a leading solution provider of medicine and health services with global influence in China. With "people-oriented and precise innovation", Tasly Pharma. constantly promotes the progress of medicine and health to make every human-being can enjoy the beauty and hope of life.
Headquartered in Tianjin, China, the company has more than 20 research centers worldwide and 11 production bases throughout the country.We are committed to cracking the digital code of life medicine. Adhering to the concept of "patient-centered", we pay close attention to the evolution of disease spectrum, and make precise innovations in major therapeutic fields such as cardio-cerebrovascular, digestion and metabolism, tumor immunity, and neuroscience, which sustain the healthy life experience of human beings.
With a rich drug combination including modern Chinese medicine, chemical medicine and biological innovation medicine, regenerative medicine and the 4-D integrated health management solutions, we can provide service of the whole health journey including health examination, early warning, prevention, diagnosis, treatment and rehabilitation and a personalized and integrated medical solutions covering the whole disease course for each patient and family so as to meet the diverse needs of the individual life, optimize life experience and improve life quality.
We continue to build an integrated platform of the whole value chain of life health, explore and develop breakthrough therapies to solve unmet clinical needs, empower medical researchers, medical staff and industry partners, and bring multidisciplinary and interdisciplinary medical innovations to the benefit of patients around the world.
Member Companies
Tasly Bio-pharma. Co., Ltd, founded in 2001, has more than 19 years of rich experiences in the field of independent R&D and commercialization of biological pharmaceutical products, and has formed a complete and mature commercialization platform integrating research and development, production and sales.As an innovative bio-pharmaceutical enterprise, it has established a sound bio-pharmaceutical research and development system, enriching the product pipeline through independent research and development, authorization and introduction, cooperative development and acquisition of commercial rights.It currently has a portfolio of 16 bio-pharmaceutical products in the three therapeutic areas of cardio-cerebrovascular, tumor and autoimmune, and digestion and metabolism, aiming to provide first-in-class or best-in-class bio-pharmaceutical products at reasonable prices to meet the growing clinical needs in targeted therapeutic areas. Possessed with a strong scientific research strength, Tasly Bio-pharma has hosted and participated in three national science and technology projects in terms of "major new Drug innovation" and other scientific research projects such as three torch plans, new product plan and biomedical industry transformation.PuYouKe (PUK), which was successfully developed and commercialized by Talsy Bio-pharma, is the national Class I biological medicine and the only approved listing recombinant human urokinase original product in China. It is expected to become a blockbuster products in the field of treatment of cardiovascular and cerebrovascular therapy in China.
Unfolding
<
Tasly Diyi Pharmaceutical Co., Ltd, located in biological medicine Industrial Park, Qingjiangpu District, Huai 'an, Jiangsu, is one of the top 100 chemical pharmaceutical enterprises of Chinese Chemical Industry Pharmaceutical Association. It mainly produces chemical API and oral solid preparation (tablet, capsule) in the fields of anti-tumor, cardiovascular, mental and liver protection. It has a chemical API manufacturing platform with an annual output of 300T (anti-tumor API and ordinary API), and a manufacturing platform with an annual output of 2.2 billion tablets (tablets) for ordinary solid preparations and anti-tumor solid preparations. All the dosage forms have passed Chinese new version GMP certification, and the API has passed EU GMP certification, Korean GMP certification, and Japanese GMP certification. The company has also passed the ISO14001 environmental management system certification, ISO9001 quality management system, and OHSAS18001 occupational health and safety evaluation system certification and was selected as the fourth batch of green manufacturing factories by the Ministry of Industry and Information Technology.
Unfolding
<
Health Products and Service
Guizhou Guotai Liquor Co.,Ltd
Guizhou Guotai Liquor Co., Ltd., the second largest government-licensed liquor enterprise in Maotai Town, has three production bases of Guotai Wine Industry, Guotai Winery and Guotai Huaijiu, with an annual output of nearly 10,000 tons of authentic Daqu Maotai-flavor liquor and over 30,000 tons of maotai-flavor liquor stored in storage years. It has employed more than 3,200 people and paid more than 5 billion yuan in taxes and fees.As of June 30, 2020, the total assets of the company exceeded 5 billion yuan.It has been awarded the titles of "National Advanced Private Enterprise in Employment and Social Security", "Five-star Enterprise in Social Responsibility performance of Guizhou Province", and has been rated as "Top two Hundred Enterprises" in Guizhou province for six consecutive years.Guotai brand has won more than 100 awards, including nomination award of Guizhou Provincial Governor's Quality Award, two Brussels International Gold Award, two Guizhou Top Ten Wine Gold Award, and the only Gold Award of Chinese Liquor in the 73rd WSWA Spirits Competition in the United States. It has been selected as the "Brand Power Project" by CCTV for four consecutive years, and its brand value reached 55.368 billion yuan in 2020. It has been successfully promoted into the mainstream liquor brand of Moutai-flavor liquor and the first-line liquor enterprise in China.
Unfolding
<
Tasly Deepure Biological Tea Group Co. Ltd
Tasly Deepure Biological Tea Group Co., Ltd. , located in Pu 'er City, Yunnan Province, mainly engaged in scientific research and development of modern biological Pu 'er tea, standardized production and sales of biological Pu 'er tea and ready-to-drink Pu 'er tea drinks and other products. Tasly Deepure Biological Tea Valley, where the company is located, perfectly combines tea cultural inheritance, technological innovation and architectural art, realizing a series of integrated technology, operation and management innovation. In 2017, it won the honor of one of the first ten Industrial tourism Demonstration bases in China (there are 10 in China and the first one in Yunnan Province). In 2018, it passed the recognition of national AAAA tourist attractions.
Unfolding
<
Digital Herbal Testing Technology Co., Ltd
Digital Herbal Testing Technology Co., Ltd., founded on July 17, 2015, is located in in Anguo Digital Traditional Chinese Medicine Center. Anguo City, Hebei Province, which is known as the "millennium Chinese medicine capital". Based on the third-party testing services of traditional Chinese medicine, the company innovates the scientific and technological service mode of traditional Chinese medicine and creates the first brand of "digital herbal testing" by building an information-based, traceable and one-stop service system. Centering on the authentic production areas and trading centers of medicinal materials, the company focuses on construction and multi-point layout. With Anguo as the center laboratory, the company has established producing area testing sub-centers in Longxi, Wenshan and other places, with a national laboratory area of more than 13,000 square meters. The company can carry out testing business according to The Chinese Pharmacopoeia, the United States/European Pharmacopoeia, national standard or import and export standard, etc. There are three test laboratories, which have all passed the CMA certification and CNAS accreditation, engaging in identification and testing. The identification service covers Chinese herbal medicine/Chinese medicine decoction pieces, pharmaceutical accessories, agricultural products, food, water, and soil, etc. The testing items include characters, physical parameters, physicochemical indexes, content determination, pesticide residues, heavy metals, aflatoxin, microorganism, DNA molecular identification of Chinese medicinal materials, etc. Digital Herbal E-commerceDigital Herbal of TCM E-commerce Co., Ltd , which is established in July 2015 formally launched trial operation in March 26, 2016. It is committed to build domestic online trading service platform of Chinese medicinal materials and provide the omni-directional "one-stop" , fast and convenient service to domestic pharmaceutical companies, drug, herbalist and terminal consumer participants of Chinese herbal medicine industry. Digital Herbal Tracing Company The Company has undertaken two national projects, the national traditional Chinese medicine circulation tracing system of the Ministry of Commerce and Chinese herbal medicine supply guarantee platform of the Ministry of Industry and Information Technology. On this basis, the Company developed a digital herbal tracing platform to provide tracing service for the local medicinal herb collector, herb dealers and enterprises.
Unfolding
<
Jilin Tasly Mineral Drinks Co., Ltd
Jilin Tasly Mineral Drinks Co., Ltd. which was established in 2009, is located at the foot of the beautiful Changbai Mountain, Jingyu Mineral Spring City of Changbai Mountain in China (one of the world's three high quality water sources) - Jingyu County, Jilin Province. Relying on changbai Mountain mineral water resources advantages, the company applies pharmaceutical standards to produce health drinks. It is committed to creating a modern health drinks production base with the ability of production and R&D of high-quality natural mineral water and health drinks.The total investment of the project is 800 million yuan, of which 437 million yuan has been invested.The overall construction covers an area of 140 mu, and the construction area has been put into operation about 57,000 square meters.At present, the main products include Cellular Vitality natural mineral water, 8L natural mineral water in bags and 10L natural mineral water in boxes with taps.
Unfolding
<
Medical Service & Health Management
Juzhi Great Health Co.,Ltd
Juzhi Great Health Co.,Ltd is an internet technology platform enterprise incubated by Tasly Group. Adhering to the mission of creating a new digital health life, the company takes the Internet hospital and chronic disease management platform as the entrance to create convenient online health consultation, online outpatient prescription renewal, online health management, online drug ordering and other patient links as well as intelligent patient electronic health record management, prescription online circulation, medical insurance network and online settlement, automatic inventory matching and automatic drug sorting, high-quality drug distribution and other patient services. It has built a new integrated service system of pre-diagnosis, in-diagnosis and post-diagnosis, and formed an online and offline digital health function network, aiming to become a leading digital platform for the great health industry.
Unfolding
<
Tasly Hospital
In cooperation with Tianjin Medical University General Hospital and several large medical institutions in Tianjin, Tasly Hospital is operated by a professional medical management team and employs well-known domestic medical experts to provide health examination, basic medical treatment, characteristic medical treatment, family medical care and other health services. It highlights the characteristics of health examination, pediatrics, stomatology, Traditional Chinese medicine and ophthalmology, aiming to build a high-end medical brand of Tasly great health industry and become a high-end medical diagnosis, treatment and health examination center in northern Tianjin.
Unfolding
<
Children Education
Cathy Future Northern Center · Tianren Wisdom Kindergarten
Cathy Future North Center · Tianren Wisdom Kindergarten is a "one-stop children health education service complex managed and operated by Tianjin Cathy Future Culture and Education Development Group Co., LTD., under the leadership of Cathy Future Culture and Art Foundation. Adhering to the education philosophy of "unity of man and nature, combining learning with practice", it is committed to educate children with the target of "physical health, versatile talent and good morals” . Located in the hinterland of Beijing-Tianjin-Hebei region and tianjin Beichen District, the Kindergarten covers an area of 120 mu, with a total construction area of nearly 50,000 square meters. The educational services mainly include: Tianren Wisdom Lapdatto Early Education Center, Cathy Future Tianren Wisdom Kindergarten, Tianren Wisdom Pre-school Thinking Training Center and Tianren Wisdom Children's Art Center", etc. High-end projects related to children's health management services, children's popular science education services, children's camp extension education services are also under construction and development. In order to realize the development goal of becoming "headquarters demonstration center, project R&D center, education incubation center and regional cultural center", the smart theater and other facilities serving children's "competitions and performances" and parent-child theme restaurants supporting children's "shopping and tourism" have been put into use.
Unfolding
<
After more than ten years of development, Tasly Capital has become an asset management entity group that covers the whole field of great health industry and integrates venture capital fund, PE fund, M&A fund and asset management.Adhering to the development idea of "enabling innovation, linking industry and finance", Tasly Capital focuses on the value investment and precision investment of great health industry. Adhering to the "patient-centered" 4D investment model, with equity as the link, it comprehensively layout Diagnosis, Drug, Device and Digital fields centering on future diagnosis and treatment models.It is committed to becoming an asset management platform respected by consumers, entrepreneurs and investors in the great health industry.
Achievements in Decade Years Development
Tasly Capital, founded in 2007, is an industrial investment platform gradually incubated, developed and expanded by Tasly Holding Group. Adhering to the development orientation of "industry oriented, finance as instrument and interaction between industry and finance". its business covers equity investment, industrial merger and acquisition, asset management and international investment. As a market-oriented industrial capital platform, Tasly Capital has achieved fruitful investment performance and investment returns since its establishment.
Data as of 2021
Efficiently activate the growth of industrial groups
Tasly Capital gives full play to the advantages of industrial capital and actively carries out two-way empowerment between industry and capital, providing powerful support for Tasly Holding Group to accurately develop projects, rationally allocate projects and integrate and create projects.
Building a function network of great-health service, Tasly Capital actively seeks to establish cooperation with industrial companies under Tasly Holding Group in terms of research, production, marketing and investment so as to empower each other and form a functional great-health management network.
As the "new driving force" for the future development of industrial groups, Tasly Capital applies incubation of industrial projects for resources reserve so as to improve the efficiency of mergers and acquisitions and capital use.
As the "searchlight" of the Group's strategic layout, Tasly Capital has extensive access to investment opportunities and to explore new technologies, new business models and new knowledge and information.
Efficiently activate the growth of industrial groups
Tasly Capital gives full play to the advantages of industrial capital and actively carries out two-way empowerment between industry and capital, providing powerful support for Tasly Holding Group to accurately develop projects, rationally allocate projects and integrate and create projects.
AI+ enabling: AI+ new drug development; AI+ imaging diagnosis; AI+ pharmaceutical preparations; Digital intelligent new drug delivery system; Big data-driven product design innovation; Digital payment innovation; Precision health management; Accurate diagnosis
Chronic disease health management function network: diabetes health management function network; Cardiovascular and cerebrovascular disease health management function network
Combination of soft and hard digital intelligent medical devices: surgical robot; Smart wearable devices
Digital medicine: Medical-grade brain-computer interface; Digital drugs for neurodegenerative diseases and attention deficit disorders
Doctor-patient link + Supply chain system
High-value consumables: innovative consumables with high clinical advantages for neural intervention; Heart valves (mitral valve; Tricuspid valve); Electrophysiology (pulse ablation; Cryoablation); Peripheral vascular intervention consumables (stent, balloon); Orthopedics and rehabilitation innovation materials; Ophthalmic innovative materials; Dental implant and orthodontic consumables
Medical equipment: surgical robots; 3D printed implanted devices; Wearable medical devices
IVD diagnosis: Upstream raw materials of IVD reagent; Early screening of tumor; Companion diagnosis; Genetic testing
IVD equipment: POCT for molecular diagnosis; Mass spectrometry detector; Endoscopy; Flow cytometer
Cell therapy: Stem cells; Immune cells (application of generic cell therapy in solid tumors); Therapeutic vaccines and other immunotherapies
Gene therapy: mRNA vaccine (technology platform); Viral vector gene therapy; Small nucleic acid drugs; Gene editing technology
Small molecule drugs: small molecule antiviral drugs; Small molecule protein degradation (PROTAC, AUTAC, molecular glue, etc.)
Macromolecule drugs: double antibody and polyantibody; Antibody-coupled drugs (ADC)
Innovation platform technology: synthetic biology technology platform; Innovative drug delivery systems; YaoXie combination
Innovative drug R&D and production outsourcing service: CXO
Develop global resources and share health achievements Build excellent integrated brand marketing model
Following the national "Belt and Road" initiative, we strive to promote the modernization and international development of TCM and carry out the development strategy of "going abroad, getting in and going up". With the opportunity of Compound Danshen Dripping Pill entering the international mainstream market, we develop world-class drugs through technical cooperation and integration of advanced resources of international market. A platform is established through brand cultivation, investment, acquisition and merger, supported by traditional Chinese medicine education and integrated Chinese and Western medicine diagnosis. And an integrated international medical service model, including trading of functional food, health care products, Chinese medicinal materials and decoction pieces, has been formed.
Tasly Pharmaceuticals Inc
Tasly Pharmaceuticals, Inc. (TaslyUS), was founded in 2006 and is based in Rockville, Maryland. As the overseas headquarter of Tasly Group, Tasly US is in charge of clinical research, scientific evaluation, pharmaceutical administration registration, technical cooperation, brand promotion and market expansion of biomedical products for Tasly Group and its cooperative enterprises around the world. At the same time, it is also an important window for Tasly Group to exchange information at home and abroad, introduce international advanced technology and talents, establish international academic and business cooperation, develop products for international market demand, connect international capital and promote the internationalization of Tasly brand.
Unfolding
<
International Medical services
We strive to steadily promote the development of integrated Traditional Chinese and Western medical platform and Chinese medicine education platform. Till present, we have set up Tasly Healthpac Medicine Group in Australia, Tasly Vivacare Medical Group in Canada and Tasly (Germany) Medical Health Management Co.,Ltd in Germany.
津公网安备 12011302120117